All-trans retinoic acid can regulate the expressions of gelatinases and apolipoprotein E in glomerulosclerosis rats

Vascular Pharmacology

Volumn 55, Issue 5-6, 2011, Pages 169-177

  Zhou, Tian Biao ^a   Qin, Yuan Han ^a   Ou, Chao ^b   Lei, Feng Ying ^a   Su, Li Na ^a   Huang, Wei Fang ^a   Zhao, Yan Jun ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Apolipoprotein E; Extracellular matrix; Gelatinases; Glomerulosclerosis; Matrix metalloproteinase 2; Matrix metalloproteinase 9

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; APOLIPOPROTEIN E; COLLAGEN TYPE 4; CREATININE; DOXORUBICIN; FIBRONECTIN; GELATINASE A; GELATINASE B; MESSENGER RNA; NITROGEN; PROTEIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; UREA NITROGEN BLOOD LEVEL;

ANIMALS; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; DOWN-REGULATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; KIDNEY GLOMERULUS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROTECTIVE AGENTS; PROTEINURIA; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA1; TRETINOIN;

EID: 84856687362     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.08.223     Document Type: Article

References (77)

1. Abe H., Matsubara T., Arai H., Doi T. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker. Histol. Histopathol. 2011, 26:531-541.
2. Adan V.S., Javier A.M., Marisol R., Jaime G.M., Dolores U.B., Rita G.D., Jorge E.D., La Pena, Esteban J.P., Miguel C. Association of polymorphisms within the transforming growth factor-b1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology (Carlton) 2010, 15:644-648.
3. Amara N., Goven D., Prost F., Muloway R., Crestani B., Boczkowski J. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 2010, 65:733-738.
4. An J., Wei Q., Liu Z., Lu K.H., Cheng X., Mills G.B., Wang L.E. Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis. Int. J. Mol. Epidemiol. Genet. 2010, 1:1-10.
5. Calandra S., Gherardi E., Fainaru M., Guaitani A., Bartosek I. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. Biochim. Biophys. Acta 1981, 665:331-338.
6. Cedazo-Minguez A., Hamker U., Meske V., Veh R.W., Hellweg R., Jacobi C., Albert F., Cowburn R.F., Ohm T.G. Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures. Neuroscience 2001, 105:651-661.
7. Choi S.E., Jang H.J., Kang Y., Jung J.G., Han S.J., Kim H.J., Kim D.J., Lee K.W. Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice. Vascul. Pharmacol. 2010, 53:264-272.
8. Cortes-Reynosa P., Robledo T., Macias-Silva M., Wu S.V., Salazar E.P. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol. 2008, 27:220-231.
9. Cury J.L., Brunetto A.F., Aydos R.D. Negative effects of chronic kidney failure on lung function and functional capacity. Rev. Bras. Fisioter. 2010, 14:91-98.
10. Danilewicz M., Wagrowska-Danielwicz M. Morphometric and immunohistochemical insight into focal segmental glomerulosclerosis in obese and non-obese patients. Nefrologia 2009, 29:35-41.
11. Darmanin S., Chen J., Zhao S., Cui H., Shirkoohi R., Kubo N., Kuge Y., Tamaki N., Nakagawa K., Hamada J., Moriuchi T., Kobayashi M. All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors. J. Immunol. 2007, 179:4616-4625.
12. Deighan C.J., Caslake M.J., McConnell M., Boulton-Jones J.M., Packard C.J. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. Kidney Int. 2000, 58:1238-1246.
13. Diao J.S., Xia W.S., Yi C.G., Wang Y.M., Li B., Xia W., Liu B., Guo S.Z., Sun X.D. Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. Arch. Dermatol. Res. 2011, 303:573-580.
14. Duan X.H., Dong J.C., He L.Q. Effect of Bushen Huoxue recipe on the state of extracellular matrix in glomerulosclerosis rats model. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010, 30:1197-1200.
15. Duran-Vilaregut J., Del V.J., Manich G., Camins A., Pallas M., Vilaplana J., Pelegri C. Role of MMP-9 in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease. Neuropathol. Appl. Neurobiol. 2011, 37:525-537.
16. Edwards P.A., Kennedy M.A., Mak P.A. LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul. Pharmacol. 2002, 38:249-256.
17. Farooqui T., Farooqui A.A. Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Park. Dis. 2011, 2011:247467.
18. Fenyo I.M., Florea I.C., Raicu M., Manea A. Tyrphostin AG490 reduces NAPDH oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein E-deficient mice. Vascul. Pharmacol. 2011, 54:100-106.
19. Finnson K.W., Parker W.L., Chi Y., Hoemann C.D., Goldring M.B., Antoniou J., Philip A. Endoglin differentially regulates TGF-beta-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage 2010, 18:1518-1527.
20. Ha K.T., Lee T.K., Kwak K.H., Kim J.K., Kim D.I., Choi D.Y., Kim C.H. Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity. Vascul. Pharmacol. 2004, 41:83-90.
21. Hakki A., Mehmet K., Fulya Y.C., Serhan T., Cetin O., Emel A. Histopathological changes and tumour necrosis factor-α, transforming growth factor-β and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission. Nephrology (Carlton) 2009, 14:219-226.
22. Hu X., Beeton C. Detection of functional matrix metalloproteinases by zymography. J. Vis. Exp. 2010, 45:2445.
23. Hu P., Qin Y.H., Pei J., Lei F.Y., Hu B., Lu L. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: a comparative study between ATRA and benazepril. Exp. Mol. Pathol. 2010, 89:51-57.
24. Hwang I.K., Park S.M., Kim S.Y., Lee S.T. A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochim. Biophys. Acta 2004, 1702:79-87.
25. Joshi S., Guleria R.S., Pan J., Dipette D., Singh U.S. Heterogeneity in retinoic acid signaling in neuroblastomas: role of matrix metalloproteinases in retinoic acid-induced differentiation. Biochim. Biophys. Acta 2007, 1772:1093-1102.
26. Joss N., Jardine A., Gaffney D., Boulton-Jones J.M. Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Exp. Nephrol. 2005, 101:e127-e133.
27. Jr Sledge G.W., Qulali M., Goulet R., Bone E.A., Fife R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J. Natl. Cancer Inst. 1995, 87:1546-1550.
28. Kaouthar M., Faical J., Abdelmajid K., Basma H., Mohamed B.H., Hafedh M., Tahia B., Rchid J., Jamil H., Hammadi A. Renal α-smooth muscle actin: a new prognostic factor for lupus nephritis. Nephrology (Carlton) 2009, 14:499-505.
29. Kunugi S., Shimizu A., Kuwahara N., Du X., Takahashi M., Terasaki Y., Fujita E., Mii A., Nagasaka S., Akimoto T., Masuda Y., Fukuda Y. Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury. Lab. Invest. 2011, 91:170-180.
30. Lackey D.E., Hoag K.A. Vitamin A upregulates matrix metalloproteinase-9 activity by murine myeloid dendritic cells through a nonclassical transcriptional mechanism. J. Nutr. 2010, 140:1502-1508.
31. Lackey D.E., Ashley S.L., Davis A.L., Hoag K.A. Retinoic acid decreases adherence of murine myeloid dendritic cells and increases production of matrix metalloproteinase-9. J. Nutr. 2008, 138:1512-1519.
32. Lamy S., Lachambre M.P., Lord-Dufour S., Beliveau R. Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells. Vascul. Pharmacol. 2010, 53:200-208.
33. Langmann T., Liebisch G., Moehle C., Schifferer R., Dayoub R., Heiduczek S., Grandl M., Dada A., Schmitz G. Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux. Biochim. Biophys. Acta 2005, 1740:155-161.
34. Lee S.Y., Horbelt M., Mang H.E., Knipe N.L., Bacallao R.L., Sado Y., Sutton T.A. MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 2011, 301:F101-F109.
35. Lin C.T., Xu Y.F., Wu J.Y., Chan L. Immunoreactive apolipoprotein E is a widely distributed cellular protein. Immunohistochemical localization of apolipoprotein E in baboon tissues. J. Clin. Invest. 1986, 78:947-958.
36. Lin W., Tsai W.L., Shao R.X., Wu G., Peng L.F., Barlow L.L., Chung W.J., Zhang L., Zhao H., Jang J.Y., Chung R.T. Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 2010, 138(2509-2518):2518.
37. Liu H., Liu F., Peng Y., Liu Y., Li L., Tu X., Cheng M., Xu X., Chen X., Ling G., Sun L. Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy. Inflamm. Res. 2010, 59:551-559.
38. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
39. Madro A., Kurzepa J., Czechowska G., Slomka M., Celinski K., Szymonik-Lesiuk S. Erythropoietin inhibits liver gelatinases during galactosamine-induced hepatic damage in rats. Pharmacol. Rep. 2009, 61:917-923.
40. Mathivadhani P., Shanthi P., Sachdanandam P. Effect of Semecarpus anacardium nut extract on ECM and proteases in mammary carcinoma rats. Vascul. Pharmacol. 2007, 46:419-426.
41. Mehan R.S., Greybeck B.J., Emmons K., Byrnes W.C., Allen D.L. Matrix Metalloproteinase-9 Deficiency Results in Decreased Fiber Cross-Sectional Area and Alters Fiber Type Distribution in Mouse Hindlimb Skeletal Muscle. Cells Tissues Organs 2011, 194:510-520.
42. Montesano R., Soulie P. Retinoids induce lumen morphogenesis in mammary epithelial cells. J. Cell Sci. 2002, 115:4419-4431.
43. Moreno-Manzano V., Mampaso F., Sepulveda-Munoz J.C., Alique M., Chen S., Ziyadeh F.N., Iglesias-de L.C.M., Rodriguez J., Nieto E., Orellana J.M., Reyes P., Arribas I., Xu Q., Kitamura M., Lucio C.F. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br. J. Pharmacol. 2003, 139:823-831.
44. Mukhopadhyay P., Rajesh M., Batkai S., Kashiwaya Y., Hasko G., Liaudet L., Szabo C., Pacher P. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1466-H1483.
45. Nie D., Ishikawa Y., Yoshimori T., Wuthier R.E., Wu L.N. Retinoic acid treatment elevates matrix metalloproteinase-2 protein and mRNA levels in avian growth plate chondrocyte cultures. J. Cell. Biochem. 1998, 68:90-99.
46. Obulesu M., Venu R., Somashekhar R. Lipid peroxidation in Alzheimer's Disease: emphasis on metal-mediated neurotoxicity. Acta Neurol. Scand. 2011, 124:295-301.
47. Ogawa K., Chen F., Kuang C., Chen Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem. J. 2004, 381:413-422.
48. Pal S., Chen Z., Xu X., Mikhailova M., Steffensen B. Co-purified gelatinases alter the stability and biological activities of human plasma fibronectin preparations. J. Periodontal Res. 2010, 45:292-295.
49. Palese M.A., Crone J.K., Burnett A.L. A castrated mouse model of erectile dysfunction. J. Androl. 2003, 24:699-703.
50. Pan G.D., Yang J.Q., Yan L.N., Chu G.P., Liu Q., Xiao Y., Yuan L. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro. World J. Gastroenterol. 2009, 15:431-440.
51. Park J.H., Park S.M., Park S.H., Cho K.H., Lee S.T. Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14. Proteomics 2008, 8:2926-2935.
52. Pastorino F., Loi M., Sapra P., Becherini P., Cilli M., Emionite L., Ribatti D., Greenberger L.M., Horak I.D., Ponzoni M. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor. Clin. Cancer Res. 2010, 16:4809-4821.
53. Perez A., Thuillard J.L., Bentzen C.L., Niesor E.J. Expression of nuclear receptors and apo E secretion during the differentiation of monocytic THP-1 cells into macrophages. Cell Biol. Toxicol. 2003, 19:95-105.
54. Piroozmand A., Hassan Z.M. Evaluation of natural killer cell activity in pre and post treated breast cancer patients. J. Cancer Res. Ther. 2010, 6:478-481.
55. Qin L., Wang Y.L., Bai S.X., Ji S.H., Qiu W., Tang S., Piao Y.S. Temporal and spatial expression of integrins and their extracellular matrix ligands at the maternal-fetal interface in the rhesus monkey during pregnancy. Biol. Reprod. 2003, 69:563-571.
56. Qin Y.H., Zhou T.B., Lei F.Y., Huang W.F., Zhao Y.J., Lin F.Q., Su L.N. Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children?. Nephrology (Carlton) 2011, 16:93-99.
57. Raij L., Azar S., Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984, 26:137-143.
58. Reilly M., Rader D.J. Apolipoprotein E and coronary disease: a puzzling paradox. PLoS Med. 2006, 3:258.
59. Russi G., Furci L., Leonelli M., Magistroni R., Romano N., Rivasi P., Albertazzi A. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report. J. Med. Case Rep. 2009, 3:9311.
60. Saito Y., Okamura M., Nakajima S., Hayakawa K., Huang T., Yao J., Kitamura M. Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway. Am. J. Physiol. Renal Physiol. 2010, 298:F1436-F1444.
61. Sarnak M.J., Wang S.R., Beck G.J., Kusek J.W., Selhub J., Greene T., Levey A.S. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. Am. J. Kidney Dis. 2002, 40:932-939.
62. Schaier M., Liebler S., Schade K., Shimizu F., Kawachi H., Grone H.J., Chandraratna R., Ritz E., Wagner J. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J. Mol. Med. 2004, 82:116-125.
63. Setz C., Brand Y., Radojevic V., Hanusek C., Mullen P.J., Levano S., Listyo A., Bodmer D. Matrix metalloproteinases 2 and 9 in the cochlea: expression and activity after aminoglycoside exposition. Neuroscience 2011, 181:28-39.
64. Song J., Meng L., Li S., Qu L., Li X. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Vascul. Pharmacol. 2009, 50:185-193.
65. van Goor H., van der Horst M.L., Atmosoerodjo J., Joles J.A., van Tol A., Grond J. Renal apolipoproteins in nephrotic rats. Am. J. Pathol. 1993, 142:1804-1812.
66. Wagner J., Dechow C., Morath C., Lehrke I., Amann K., Waldherr R., Floege J., Ritz E. Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J. Am. Soc. Nephrol. 2000, 11:1479-1487.
67. Wang W., Liu F., Chen N. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediators Inflamm. 2007, 2007:62641.
68. Wang H., Dan Z., Jiang H. Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2008, 28:553-557.
69. Wang Z., Zhang J.N., Hu X.F., Chen X.L., Wang X.R., Zhao T.T., Peng M.J., Zou P. Effects of pentoxifylline on Wnt/beta-catenin signaling in mice chronically exposed to cigarette smoke. Chin. Med. J. (Engl) 2010, 123:2688-2694.
70. Wong W., DeVito J., Nguyen H., Sarracino D., Porcheray F., Dargon I., Pelle P.D., Collins A.B., Tolkoff-Rubin N., Smith R.N., Colvin R., Zorn E. Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine. Am. J. Transplant. 2010, 10:2463-2471.
71. Yue L., Mazzone T. Endogenous adipocyte apolipoprotein E is colocalized with caveolin at the adipocyte plasma membrane. J. Lipid Res. 2011, 52:489-498.
72. Yutaka K., Atsuhito N., Chisei R.A., Ko O., Eri M., Hideoki O., Ikei K., Satoshi H., Yasukiko T. Role of transforming growth factor-β/Smad signalling pathway in enhanced production of glomerular extracellular matrix in IgA nephropathy of high-serum-IgA ddY mice. Nephrology (Carlton) 2002, 7:S151-155.
73. Zhang X.M., Huang S.P., Xu Q. Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother. Pharmacol. 2004, 53:82-88.
74. Zhang Y., Huang P., Jiang T., Zhao J., Zhang N. Role of aldose reductase in TGF-beta1-induced fibronectin synthesis in human mesangial cells. Mol. Biol. Rep. 2010, 37:2735-2742.
75. Zhou G., Dada L.A., Wu M., Kelly A., Trejo H., Zhou Q., Varga J., Sznajder J.I. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L1120-L1130.
76. Zhou T.B., Qin Y.H., Lei F.Y., Su L.N., Zhao Y.J., Huang W.F. apoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats. Ren. Fail. 2011, 33:348-354.
77. Zhou T.B., Qin Y.H., Lei F.Y., Su L.N., Zhao Y.J., Huang W.F. All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by Adriamycin. Exp. Mol. Pathol. 2011, 90:287-294.